Parnell Pharmaceuticals (CE) Stock Quote PARNF - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.12

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

0.000001 52 Week Range 0.35

Market Cap

14.445M

Previous Close

0.12

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

31,574

Shares Outstanding

120,377,529

Dividend Yield

PE Ratio

-2.52

Earnings Per Share (EPS)

-0.05

Revenue

35.43M

Net Profit

-5.74M

Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed... Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed via its dedicated sales force and digital technology mySYNCH in the USA and Australia-New Zealand, and via distributors in other markets. Parnell has a rapidly growing contract manufacturing business supplying industry majors with specialized sterile injectable products. In companion animal, Parnell manufactures and markets its proprietary canine osteoarthritis brands Zydax and Glyde. For more information on the company and its products, please visit www.parnell.com. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.parnell.com

Headquarters

Sydney, New South Wales, Aus

Founded

Parnell Pharmaceuticals Holdings Ltd (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PARNF. The last closing price for Parnell Pharmaceuticals (CE) was $0.12. Over the last year, Parnell Pharmaceuticals (CE) shares have traded in a share price range of $ 0.000001 to $ 0.35.

Parnell Pharmaceuticals (CE) currently has 120,377,529 shares outstanding. The market capitalization of Parnell Pharmaceuticals (CE) is $14.45 million. Parnell Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of -2.52.

Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...

OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.12	0.12	0.12	45195	0.12	CS
4	0.07	140	0.05	0.35	0.05	23997	0.12424914	CS
12	0.07	140	0.05	0.35	0.05	31574	0.08762036	CS
26	0.1199	119900	0.0001	0.35	1.0E-6	22244	0.08610534	CS
52	0.119999	11999900	1.0E-6	0.35	1.0E-6	15625	0.08387349	CS
156	0.1198	59900	0.0002	0.35	1.0E-6	13312	0.02874939	CS
260	-0.03	-20	0.15	0.89	1.0E-6	12403	0.21470599	CS

PARNF - Frequently Asked Questions (FAQ)

What is the current Parnell Pharmaceuticals (CE) share price?

The current share price of Parnell Pharmaceuticals (CE) is $ 0.12

How many Parnell Pharmaceuticals (CE) shares are in issue?

Parnell Pharmaceuticals (CE) has 120,377,529 shares in issue

What is the market cap of Parnell Pharmaceuticals (CE)?

The market capitalisation of Parnell Pharmaceuticals (CE) is USD 14.45M

What is the 1 year trading range for Parnell Pharmaceuticals (CE) share price?

Parnell Pharmaceuticals (CE) has traded in the range of $ 0.000001 to $ 0.35 during the past year

What is the PE ratio of Parnell Pharmaceuticals (CE)?

The price to earnings ratio of Parnell Pharmaceuticals (CE) is -2.52

What is the cash to sales ratio of Parnell Pharmaceuticals (CE)?

The cash to sales ratio of Parnell Pharmaceuticals (CE) is 0.41

What is the reporting currency for Parnell Pharmaceuticals (CE)?

Parnell Pharmaceuticals (CE) reports financial results in AUD

What is the latest annual turnover for Parnell Pharmaceuticals (CE)?

The latest annual turnover of Parnell Pharmaceuticals (CE) is AUD 35.43M

What is the latest annual profit for Parnell Pharmaceuticals (CE)?

The latest annual profit of Parnell Pharmaceuticals (CE) is AUD -5.74M

What is the registered address of Parnell Pharmaceuticals (CE)?

The registered address for Parnell Pharmaceuticals (CE) is UNIT 4 CENTURY ESTATE, 476 GARDENERS ROAD, ALEXANDRIA, SYDNEY, NEW SOUTH WALES, 2015

What is the Parnell Pharmaceuticals (CE) website address?

The website address for Parnell Pharmaceuticals (CE) is www.parnell.com

Which industry sector does Parnell Pharmaceuticals (CE) operate in?

Parnell Pharmaceuticals (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GTORGGToor Inc (CE)	$ 0.0001 (9,900.00%)	3.54k
INTKIndustrial Nanotech Inc (PK)	$ 0.0001 (9,900.00%)	500k
BORKBourque Industries Inc (CE)	$ 0.0001 (9,900.00%)	579.7k
PSRUValiant Eagle Inc (PK)	$ 0.0001 (9,900.00%)	200k
MOPNMOP Environmental Solutions Inc (CE)	$ 0.0001 (9,900.00%)	32k
IFANIFAN Financial Inc (CE)	$ 0.000001 (-99.50%)	1,000
VGTLVGTel Inc (CE)	$ 0.000001 (-99.50%)	200k
UBQUUbiquitech Software Corp (PK)	$ 0.000001 (-99.00%)	1.73M
GLCOGlobal Links Corporation New (CE)	$ 0.000001 (-99.00%)	1.5k
TYHJFTyhee Gold Corporation (CE)	$ 0.000001 (-95.00%)	1.8k
ABQQAB International Group Corporation (PK)	$ 0.0007 (0.00%)	124.38M
TGGITrans Global Group Inc (CE)	$ 0.0002 (100.00%)	56.33M
SIRCSolar Integrated Roofing Corporation (PK)	$ 0.0001 (0.00%)	37.8M
GTCHGBT Technologies Inc (PK)	$ 0.0002 (0.00%)	28.97M
AITXArtificial Intelligence Technology Solutions Inc (PK)	$ 0.0037 (-1.33%)	27.06M